MISSION BAY CAPITAL
Mission Bay Capital is a venture capital firm for early-stage investments.
MISSION BAY CAPITAL
Social Links:
Industry:
Financial Services Life Science Venture Capital
Founded:
2009-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Domain Not Resolving Euro Microsoft Exchange Online
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Mission BioCapital
Mission BioCapital is a life science venture capital firm that invests in early-stage companies.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-11-02 | Nitrase Therapeutics | Mission Bay Capital investment in Series A - Nitrase Therapeutics | 7 M USD |
| 2021-07-22 | Nobell Foods | Mission Bay Capital investment in Series B - Nobell Foods | 75 M USD |
| 2020-09-14 | Symbiome | Mission Bay Capital investment in Venture Round - Symbiome | 15 M USD |
| 2020-04-22 | Nitrase Therapeutics | Mission Bay Capital investment in Series A - Nitrase Therapeutics | 38 M USD |
| 2019-08-07 | Glycomine | Mission Bay Capital investment in Series B - Glycomine | 33 M USD |
| 2018-07-25 | Alector | Mission Bay Capital investment in Series E - Alector | 133 M USD |
| 2018-04-17 | GraphWear Technologies | Mission Bay Capital investment in Series A - GraphWear Technologies | 4.2 M USD |
| 2018-03-30 | Wildtype | Mission Bay Capital investment in Seed Round - Wildtype | 3.5 M USD |
| 2018-03-05 | ViewPoint Therapeutics | Mission Bay Capital investment in Series B - ViewPoint Therapeutics | 35 M USD |
| 2017-12-13 | Pionyr Immunotherapeutics | Mission Bay Capital investment in Series B - Pionyr Immunotherapeutics | 62 M USD |